Get started
Author

Martina Delle Marchette

Observed names: M. Delle Marchette, Martina delle Marchette, Martina lle De Marchette
ORCID: 0009-0003-6851-784X
Observed ORCID: 0009-0003-6851-784X
OpenAlex ID: A5082467055
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery
2019 · Martina Delle Marchette, Lorenzo Ceppi, et al. · European Journal of Cancer · 77
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy
2020 · Tineke Vandenbroucke, Magali Verheecke, et al. · European Journal of Cancer · 58
PDF
Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy
2019 · Michael J Halaska, Catherine Uzan, et al. · International Journal of Gynecological Cancer · 58
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
2020 · Lara Paracchini, Luca Beltrame, et al. · Clinical Cancer Research · 57
PDF
Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer
2015 · Alessandro Buda, Giampaolo Di Martino, et al. · International Journal of Gynecological Cancer · 34
Feasibility of sentinel lymph node mapping of the ovary: a systematic review
2019 · Federica Dell'Orto, Pim Laven, et al. · International Journal of Gynecological Cancer · 31
PDF
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients
2020 · Cinzia Crivellaro, Claudio Landoni, et al. · International Journal of Gynecological Cancer · 28
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms
2018 · Lorenzo Ceppi, Francesca Galli, et al. · Gynecologic Oncology · 27
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis
2020 · Lara Paracchini, Chiara Pesenti, et al. · JAMA Network Open · 23
PDF
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high‐grade serous ovarian cancer
2020 · Giuseppe Benvenuto, Paola Todeschini, et al. · International Journal of Cancer · 21
PDF
Multisite analysis of high‐grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3
2019 · Sara Ballabio, Ilaria Craparotta, et al. · International Journal of Cancer · 20
PDF
Minilaparoscopy vs Standard Laparoscopy for Sentinel Node Dissection: A Pilot Study
2017 · Stefano Uccella, Alessandro Buda, et al. · Journal of Minimally Invasive Gynecology · 15
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study
2019 · Enrica Calura, Matteo Ciciani, et al. · Cells · 12
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy
2024 · Giuseppe Marino, Tommaso Grassi, et al. · Frontiers in Oncology · 9
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy
2024 · Robert Fruscio, Rita Trozzi, et al. · International Journal of Gynecological Cancer · 7
Gestational Intraplacental Choriocarcinoma in a Term Pregnancy: A Case Report
2022 · Andrea Sala, Sara Ornaghi, et al. · Cureus · 7
PDF
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2
2026 · Adriana I. Apostol, Jacek Gronwald, et al. · Journal of Clinical Oncology · 6
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case–control study
2021 · Federica Sina, Chiara Cassani, et al. · International Journal of Gynecological Cancer · 4
Data from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
2023 · Lara Paracchini, Luca Beltrame, et al. · 1
Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy
2022 · Serena Negri, Elena De Ponti, et al. · Molecular Genetics & Genomic Medicine · 1
PDF
2022-RA-1020-ESGO Family history in BRCA mutation carriers affected by breast and ovarian cancer and its role in identifying subjects at high risk
2022 · Serena Negri, Elena de Ponti, et al. · International Journal of Gynecological Cancer · 1
PDF
P07.01: Artificial intelligence (AI) weights the importance of clinical and sonographic factors predicting malignancy in unilocular‐solid cysts before surgery
2019 · V. Chiappa, G. Bogani, et al. · Ultrasound in Obstetrics and Gynecology · 1
PDF
PR034/#875 Fertility sparing surgery in patients with advanced borderline ovarian tumors: oncologic and fertility outcomes of a large single-institution cohort
2024 · Tommaso Bianchi, Tommaso Grassi, et al. · International Journal of Gynecological Cancer
Supplementary Results from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
2023 · Lara Paracchini, Luca Beltrame, et al.
Figure S10 from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
2023 · Lara Paracchini, Luca Beltrame, et al.
Works count: 71
Citation count: 498
H-index: 12
I10-index: 13
Year
Topic
Type